Clinical Trial Update: A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

This clinical trial is a Phase 1 study evaluating LY4256984 in adults with sporadic amyotrophic lateral sclerosis, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• LY4256984

Snippet

Sponsor: Eli Lilly and Company | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | Status: RECRUITING